Neogen (NEOG) Change in Accured Expenses (2010 - 2026)
Neogen (NEOG) posted quarterly Change in Accured Expenses of -$700000.0 for Q2 2026, down 109.86% year-over-year from $7.1 million in Q2 2025, and down 104.48% quarter-over-quarter from $15.6 million in Q1 2026.
Neogen (NEOG) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Neogen's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$700000.0 for Q2 2026.
- In Q2 2026, Change in Accured Expenses fell 109.86% year-over-year to -$700000.0; the TTM figure through May 2026 stood at $19.8 million (up 5050.0% YoY), while the FY2026 annual figure was $19.8 million, up 5050.0% from the prior year.
- Change in Accured Expenses for Q2 2026 stood at -$700000.0, down from $15.6 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $42.7 million in Q4 2023, with the low at -$32.5 million in Q1 2023.
- The 5-year median for Change in Accured Expenses is -$4.1 million (2024), against an average of $3.4 million.
- Peak annual rise in Change in Accured Expenses reached 324.43% in 2022, while the deepest fall reached 486.9% in 2022.
- Neogen's Change in Accured Expenses stood at $37.4 million in 2022, then gained by 14.12% to $42.7 million in 2023, then plunged by 57.7% to $18.0 million in 2024, then sank by 151.59% to -$9.3 million in 2025, then surged by 92.48% to -$700000.0 in 2026.
- Business Quant data shows NEOG's Change in Accured Expenses at -$700000.0 in Q2 2026, $15.6 million in Q1 2026, and -$9.3 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 298.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 234.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 123.70 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 112.90 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 19.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 43.01 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 4.80 Mn |
| 10 | Neogen | 2.56 Bn | 2.37 Bn | 107.80 Mn | -700,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | -700,000.00 |
| May 31, 2026 | -700,000.00 |
| Feb 28, 2026 | -7.54 Mn |
| Feb 28, 2026 | -7.54 Mn |
| Nov 30, 2025 | 7.46 Mn |
| Nov 30, 2025 | 7.46 Mn |
| Aug 31, 2025 | -7.52 Mn |
| Aug 31, 2025 | -7.52 Mn |
| May 31, 2025 | -6.40 Mn |
| May 31, 2025 | -6.40 Mn |
| Feb 28, 2025 | 5.89 Mn |
| Feb 28, 2025 | 5.89 Mn |
| Nov 30, 2024 | 15.99 Mn |
| Nov 30, 2024 | 15.99 Mn |
| Aug 31, 2024 | -15.88 Mn |
| Aug 31, 2024 | -15.88 Mn |
| May 31, 2024 | 21.46 Mn |
| May 31, 2024 | 21.46 Mn |
| Feb 29, 2024 | -7.55 Mn |
| Feb 29, 2024 | -7.55 Mn |